Skip to main content

Pharmaceutical Pricing and Reimbursement and the Broader Pharmaceutical Policy Environment

Buy Article:

$24.00 plus tax (Refund Policy)

The pricing and reimbursement policies used in OECD countries are described and analysed in this chapter. It begins with a description of the coverage schemes that serve to pool risks and defray the pharmaceutical costs borne by individuals. It continues by describing the pharmaceutical pricing schemes employed in OECD countries, including the methods used to limit pharmaceutical prices and define reimbursement price levels. A concluding section provides an overview of aspects of intellectual property rights and marketing authorisation policies that are most important in defining the pharmaceutical policy environment.
No References
No Citations
No Supplementary Data
No Data/Media
No Metrics

Document Type: Review Article

Publication date: 2008-09-01

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more